Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

β-lactam antibiotics are one of the most widely used and diverse classes of antimicrobial
agents for treating both Gram-negative and Gram-positive bacterial infections. The β-lactam …

Acinetobacter baumannii is a highly antibiotic resistant Gram-negative bacterium that
causes life-threatening infections in humans with a very high mortality rate. A. baumannii is …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Carbapenem-resistant Acinetobacter baumannii causing immense treatment problems in
hospitals. There is still a knowledge gap on the abundance and stability of acquired …

Multidrug-resistant (MDR) bacteria-caused infections have been a major threat to human
health. The abuse of conventional antibiotics accelerates the generation of MDR bacteria …

Sulbactam, a class A β-lactamase inhibitor, added to cefoperazone either at a fixed 8 mg/L
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a top-priority pathogen causing a
nosocomial infection that increases morbidity and mortality. Treatment options for CRAB are …

Background Generating vaccines is a promising and effective method for stopping the
spread of Acinetobacter baumannii (A. baumannii) infections that are becoming more and …

Background. The spread of carbapenem‐resistant A. baumannii (CrAb) is gaining worldwide
attention. The spread of this pathogen is largely due to its ability to acquire various …